SARS-CoV-2 infection of primary human lung epithelium for COVID-19 modeling and drug discovery-Reference-Cited by-同舟云学术

SARS-CoV-2 infection of primary human lung epithelium for COVID-19 modeling and drug discovery

Published:2021-05 Issue:5 Volume:35 Page:109055
ISSN:2211-1247
Container-title:Cell Reports
language:en
Short-container-title:Cell Reports

Author:

Mulay Apoorva,Konda Bindu,Garcia Gustavo,Yao Changfu^ORCID,Beil Stephen,Villalba Jaquelyn M.,Koziol Colin^ORCID,Sen Chandani,Purkayastha Arunima,Kolls Jay. K.^ORCID,Pociask Derek A.,Pessina Patrizia,de Aja Julio Sainz^ORCID,Garcia-de-Alba Carolina,Kim Carla F.^ORCID,Gomperts Brigitte,Arumugaswami Vaithilingaraja,Stripp Barry R.

Publisher

Elsevier BV

Subject

General Biochemistry, Genetics and Molecular Biology

Reference37 articles.

1. Type 2 alveolar cells are stem cells in adult lung;Barkauskas;J. Clin. Invest.,2013

2. Remdesivir for the Treatment of Covid-19—Preliminary Report;Beigel;N. Engl. J. Med.,2020

3. Imbalanced Host Response to SARS-CoV-2 Drives Development of COVID-19;Blanco-Melo;Cell,2020

4. SARS-CoV-2 cellular tropism;Cagno;Lancet Microbe,2020

5. Single-Cell Reconstruction of Human Basal Cell Diversity in Normal and Idiopathic Pulmonary Fibrosis Lung;Carraro;Am. J. Respir. Crit. Care Med.,2020

Cited by 175 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Amidino-rocaglates (ADRs), a class of synthetic rocaglates, are potent inhibitors of SARS-CoV-2 replication through inhibition of viral protein synthesis;Antiviral Research;2024-10

2. Direct-acting antivirals for RSV treatment, a review;Antiviral Research;2024-09

3. Global, regional, and national burden of upper respiratory infections and otitis media, 1990–2021: a systematic analysis from the Global Burden of Disease Study 2021;The Lancet Infectious Diseases;2024-09

4. An ex vivo human precision-cut lung slice platform provides insight into SARS-CoV-2 pathogenesis and antiviral drug efficacy;Journal of Virology;2024-07-23

5. Building a human lung from pluripotent stem cells to model respiratory viral infections;Respiratory Research;2024-07-15